Next, to evaluate the role of the CXCL12-CXCR4 signaling in tumor growth, the CXCR4 antagonist AMD3100 [26] was repeatedly administered to the area adjacent to the MDA-MB-231 cell-derived tumors after the xenotransplantation. The gene discussed is CXCL12; the disease is neoplasm.